Interferon Alone or Combined with Ribavirin for Acute Prolonged Infection with Hepatitis C Virus in Chimpanzees

Authors: Tomoguri, T., Katayama, K., Tanaka, J., Yugi, H., Mizui, M., Miyakawa, Y., Yoshizawa, H.

Source: INTERVIROLOGY -BASEL-. 54(4):229-232

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN293162928&indx=1&recIds=ETOCRN293162928

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C

Authors: Komiya, Y., Katayama, K., Yugi, H., Mizui, M., Matsukura, H., Tomoguri, T., Miyakawa, Y., Tabuchi, A., Tanaka, J., Yoshizawa, H.

Source: TRANSFUSION -PHILADELPHIA-. 48(2):286-294

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN222680966&indx=1&recIds=ETOCRN222680966

Early Dynamics of Hepatitis C Virus in the Circulation of Chimpanzees with Experimental Infection

Authors: Tanaka, J., Katayama, K., Kumagai, J., Komiya, Y., Yugi, H., Kishimoto, S., Mizui, M., Tomoguri, T., Miyakawa, Y., Yoshizawa, H.

Source: INTERVIROLOGY -BASEL-. 48(2-3):120-123

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN166856230&indx=1&recIds=ETOCRN166856230

Titration of Hepatitis C Virus in Chimpanzees for Determining the Copy Number Required for Transmission

Authors: Katayama, K., Kumagai, J., Komiya, Y., Mizui, M., Yugi, H., Kishimoto, S., Yamanaka, R., Tamatsukuri, S., Tomoguri, T., Miyakawa, Y.

Source: INTERVIROLOGY -BASEL-. 47(1):57-64

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN146797865&indx=1&recIds=ETOCRN146797865

In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus

Authors: Esumi, M., Zhou, Y. H., Tanoue, T., Tomoguri, T., Hayasaka, I.

Source: VACCINE -GUILDFORD THEN LONDON THEN OXFORD-. 20(25-26):3095-3103

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN117648930&indx=1&recIds=ETOCRN117648930

Pharmacological Studies on Human Urinary Kallidinogenase (SK-827): Effects on Cerebral Metabolism

Authors: Nagano, H., Suzuki, T., Tomoguri, T., Hayashi, M.

Source: JOURNAL- PHARMACEUTICAL SOCIETY OF JAPAN. 113(11):825-825

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCEN013234589&indx=1&recIds=ETOCEN013234589

Pharmacological Studies on Human Urinary Kallidinogenase (SK-827): Cerebral Protective Effects

Authors: Nagano, H., Suzuki, T., Nakamura, S., Tomoguri, T.

Source: JOURNAL- PHARMACEUTICAL SOCIETY OF JAPAN. 113(11):803-803

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCEN013234553&indx=1&recIds=ETOCEN013234553

Pharmacological Studies of Human Urinary Kallidinogenase (SK-827) (2) Mode of Action on Blood Vessels

Authors: Suzuki, T., Hayashi, M., Tomoguri, T.

Source: PHARMACOMETRICS -SENDAI-. 45(4):375-375

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCEN006926824&indx=1&recIds=ETOCEN006926824

Pharmacological Studies of Human Urinary Kallidinogenase (SK-827) (3) Effects on Peripheral Vascular Disorders

Authors: Suzuki, T., Nagano, H., Hayashi, M., Tomoguri, T.

Source: PHARMACOMETRICS -SENDAI-. 45(4):383-383

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCEN006926836&indx=1&recIds=ETOCEN006926836

This result is not displayed to guests.
Login for full access.